"
Home Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Page43 Page44 Page45 Page46 Page47 Page48 Page49 Page50 Page51 Page52 Page53 Page54 Page55 Page56 Page57 Page58 Page59 Page60 Page61 Page62 Page63 Page64 Page65 Page66 Page67 Page68 Page69 Page70 Page71 Page72 Page73 Page74 Page75 Page76 Page77 Page78 Page79 Page80 Page81 Page82 Page83 Page84 Page85 Page86 Page87 Page88 Page89 Page90 Page91 Page92 Page93 Page94 Page95 Page96 Page97 Page98 Page99 Page100 Page101 Page102 Page103 Page104 Page105 Page106 Page107 Page108 Page109 Page110 Page111 Page112 Page113 Page114 Page115 Page116 Page117 Page118 Page119 Page120 Page121 Page122 Page123 Page124 Page125 Page126 Page127 Page128 Page129 Page130 Page131

Lincosamides and Glycopeptides: Mechanisms, Uses, and Resistance

Lincosamides

Introduction

Lincosamides are a class of antibiotics primarily effective against Gram-positive bacteria and some anaerobes. Clindamycin is the most commonly used lincosamide.

Mechanism of Action

Lincosamides inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex and interfering with peptide chain elongation.

Mechanism of Resistance

  • Modification of the ribosomal target site, leading to reduced binding affinity.
  • Efflux pumps that pump the drug out of the cell.
  • Enzymatic inactivation by bacterial enzymes.

Therapeutic Uses

  • Soft tissue infections, bone infections, and anaerobic infections.
  • Used in combination for MRSA infections.

Adverse Effects

  • Gastrointestinal disturbances (nausea, vomiting, diarrhea).
  • Risk of C. difficile-associated diarrhea.
  • Rash, blood dyscrasias, and hepatic dysfunction.

Contraindications

  • Hypersensitivity to clindamycin.
  • History of C. difficile colitis.

Glycopeptides

Introduction

Glycopeptides are antibiotics primarily used for Gram-positive bacterial infections, especially those resistant to other drugs. Vancomycin is the most commonly used glycopeptide.

Mechanism of Action

Glycopeptides inhibit bacterial cell wall synthesis by binding to the D-alanyl-D-alanine terminal of peptidoglycan precursors, preventing the formation of cross-links in the cell wall.

Mechanism of Resistance

  • Modification of the D-alanine-D-alanine target to D-alanine-D-lactate.
  • Vancomycin-intermediate *Staphylococcus aureus* (VISA) and Vancomycin-resistant *Enterococcus* (VRE).

Therapeutic Uses

  • Severe Gram-positive infections, including MRSA and *Enterococcus* infections.
  • Clostridium difficile colitis (oral vancomycin).

Adverse Effects

  • Red man syndrome (flushing, rash, hypotension).
  • Nephrotoxicity and ototoxicity (with high doses).
  • Thrombophlebitis at the injection site.

Contraindications

  • Hypersensitivity to vancomycin.
  • Renal impairment (dose adjustments required).

© 2024 Easy Notes on Pharmacology.
Privacy Policy | Contact Us Subscribe to our RSS feed